Digital
Changing Faces: Digital and supplier, January 2026
The life sciences supplier and digital health sectors witnessed significant leadership movements in January.
R&D
Sponsored
Advancing RSV and hMPV research through human challenge tria...
Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.
Patients
New hope for ovarian cancer, with Alexander Schneider
Alexander Schneider, CEO of CureLab Oncology, shares how his company’s drug candidate for platinum-resistant ovarian cancer is named after his wife.
Sales & Marketing
A fast start to 2026 signals continued investor confidence i...
Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.
Patients
Patient centricity: How pharma can move beyond the buzzwords
One important way that pharma companies can deliver true patient advocacy is by bringing cross-functional experience to the table.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
